(Q46045433)

19 December 2017

title

Antiplatelet therapy: Personalized medicine for clopidogrel resistance? (English)

1 reference

19 December 2017

1 reference

personalized medicine

1 reference

1

1 reference

19 December 2017

Valentín Fuster Carulla

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

19 December 2017

Nature Reviews Cardiology

published in

1 reference

19 December 2017

volume

6

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

334-336

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/nrcardio.2009.28

exact match

0 references

cites work

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Variability in platelet responsiveness to clopidogrel among 544 individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Diagnostic tests 4: likelihood ratios

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Cytochrome p-450 polymorphisms and response to clopidogrel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2009.28

31 March 2020

Identifiers

DOI

10.1038/NRCARDIO.2009.28

1 reference

19 December 2017

Dimensions Publication ID

1041293933

0 references

1 reference

19 December 2017